mhurhangee/ep-ind-claims huggingface dataset:
Method for producing tubular fibre-composite bodies by means of a cylindrical core body which extends in an axial direction and on which a fibrous material is deposited by a continuous depositing method, wherein the method comprises at least the following steps: - applying a coating to the core body; - applying a non-woven layer to the coating; - depositing the fibrous material on the non-woven layer so as to form at least one first fibrous layer. - applying a coating to the core body; - applying a non-woven layer to the coating; - depositing the fibrous material on the non-woven layer so as to form at least one first fibrous layer.
A method comprising: determining, by a processing device, a frame noise variance for intensity values of each frame of frames of a video, the frame noise variance being based on a determined relationship between spatial variance and temporal variance of the intensity values of blocks in the frame and based on an assumption that a noise covariance between homogeneous blocks in the video has a constant value; identifying, by the processing device, a video noise variance for the video based on frame noise variances of the frames of the video; selecting, by the processing device, for each frame of the video, one or more of the blocks having a spatial variance that is less than the video noise variance, the one or more selected blocks being labelled as homogeneous blocks; and utilizing, by the processing device, the selected homogeneous blocks to estimate a noise signal of the video. determining, by a processing device, a frame noise variance for intensity values of each frame of frames of a video, the frame noise variance being based on a determined relationship between spatial variance and temporal variance of the intensity values of blocks in the frame and based on an assumption that a noise covariance between homogeneous blocks in the video has a constant value; identifying, by the processing device, a video noise variance for the video based on frame noise variances of the frames of the video; selecting, by the processing device, for each frame of the video, one or more of the blocks having a spatial variance that is less than the video noise variance, the one or more selected blocks being labelled as homogeneous blocks; and utilizing, by the processing device, the selected homogeneous blocks to estimate a noise signal of the video.
A polynucleotide comprising a transgene, wherein the transgene comprises an immunoglobulin light chain sequence comprising completely mouse DNA except for sequences encoding human immunoglobulin light chain variable polypeptides and sequences encoding human immunoglobulin joining polypeptides replacing their mouse orthologues, wherein all of the cis regulatory sequences in the immunoglobulin light chain sequence are mouse cis regulatory sequences, and wherein the transgene, when deployed in a mouse, is capable of generating an immunoglobulin light chain comprising a human variable region.
A vertical-tailless aircraft, comprising: a body extending in a direction along an aircraft axis and including a front body and a rear body in the aircraft axis direction; a main wing provided on a side surface of the body; and a negative pressure generating portion provided at the rear body, the negative pressure generating portion configured to generate negative pressure on the side surface of the rear body in a case that the vertical-tailless aircraft sideslips, wherein the negative pressure generating portion includes an upper corner portion (62, 63) and a lower corner portion (64, 65), wherein the upper corner portion is formed between a ceiling surface of the body and the side surface, and the lower corner portion is formed between a bottom surface of the body and the side surface, characterized in that each of interior angles (θ1; θ2) of the upper and lower corner portions in a section of the rear body which section is perpendicular to the aircraft axis is 60° or more and 150° or less. a main wing provided on a side surface of the body; and a negative pressure generating portion provided at the rear body, the negative pressure generating portion configured to generate negative pressure on the side surface of the rear body in a case that the vertical-tailless aircraft sideslips, wherein the negative pressure generating portion includes an upper corner portion (62, 63) and a lower corner portion (64, 65), wherein the upper corner portion is formed between a ceiling surface of the body and the side surface, and the lower corner portion is formed between a bottom surface of the body and the side surface, characterized in that each of interior angles (θ1; θ2) of the upper and lower corner portions in a section of the rear body which section is perpendicular to the aircraft axis is 60° or more and 150° or less.
Dating system for injection molds, comprising: - a marking element that engraves a determined date; said marking element comprising interchangeable inserts that indicate said determined date, said determined date being defined by letters and/or numbers, forming a line, wherein said interchangeable inserts are removably mounted on a support, characterized in that the dating system also comprises a handling tool to place and remove said interchangeable inserts, wherein said handling tool comprises a recess for one or more interchangeable inserts, and a stop for retaining said interchangeable inserts in said recess. - a marking element that engraves a determined date; said marking element comprising interchangeable inserts that indicate said determined date, said determined date being defined by letters and/or numbers, forming a line, wherein said interchangeable inserts are removably mounted on a support, characterized in that the dating system also comprises a handling tool to place and remove said interchangeable inserts, wherein said handling tool comprises a recess for one or more interchangeable inserts, and a stop for retaining said interchangeable inserts in said recess.
A biological tissue adhesive sheet comprising a nonwoven fabric made of fibers containing a crosslinked cold-water fish gelatin, wherein the cold-water fish gelatin is at least one selected from the group consisting of cod gelatin, sea bream gelatin, salmon gelatin, and a genetically-engineered gelatin derived from cod, sea bream, or salmon, and wherein the nonwoven fabric has a thickness in a range from 100 μm to 500 μm. wherein the cold-water fish gelatin is at least one selected from the group consisting of cod gelatin, sea bream gelatin, salmon gelatin, and a genetically-engineered gelatin derived from cod, sea bream, or salmon, and wherein the nonwoven fabric has a thickness in a range from 100 μm to 500 μm.
A catheter sheath introducer adapted for use with a medical device, comprising: a hub; an elongated sheath comprising a tubular structure with a distal end and a proximal end, the tubular structure having at least one layer with an inner circumferential surface defining a lumen, the hub being connected to the proximal end of the sheath; and one or more pairs of diametrically opposing dampers, wherein the dampers: extend inwardly from the inner circumferential surface of the lumen of the sheath; are angled toward the distal end of the sheath in a unidirectional configuration, such that the medical device encounters less frictional impedance when advanced distally relative to the sheath than when withdrawn proximally relative to the sheath; are configured to contact and apply a retention force on the medical device received in the lumen of the sheath, and wherein distal ends of the one or more pairs of diametrically opposing dampers are out of contact with each other when the medical device is out of contact with the dampers. a hub; an elongated sheath comprising a tubular structure with a distal end and a proximal end, the tubular structure having at least one layer with an inner circumferential surface defining a lumen, the hub being connected to the proximal end of the sheath; and one or more pairs of diametrically opposing dampers, extend inwardly from the inner circumferential surface of the lumen of the sheath; are angled toward the distal end of the sheath in a unidirectional configuration, such that the medical device encounters less frictional impedance when advanced distally relative to the sheath than when withdrawn proximally relative to the sheath; are configured to contact and apply a retention force on the medical device received in the lumen of the sheath, and
A bracket for movable roofs and facades, comprising a load introduction plate, a mechanical interface and two elastomer bearings, wherein the load introduction plate has a base surface and at least one side surface, wherein the mechanical interface comprises at least one rib, a first bearing plate arranged on the at least one rib and a second bearing plate arranged on the at least one rib, wherein a first elastomer bearing, in particular a first EPDM bearing, is arranged between the base surface of the load introduction plate and the first bearing plate, and a second elastomer bearing, in particular a second EPDM bearing, is arranged between the second bearing plate and the side surface of the load introduction plate.
A method for operating a first communications controller serving a first device, the method comprising: • receiving, by the first communications controller, channel information for a communications channel between the first communication controller and a second device served by a second communications controller, wherein the channel information comprises a channel covariance matrix providing directional information of the second communication controller and the second device (step 705); • deriving, by the first communications controller, a time-frequency resource, a duration, and a precoding constraint in accordance with the received channel information, the precoding constraint being derived using said channel covariance matrix, and the precoding constraint being for use with a transmission of the first communications controller occurring within the time-frequency resource for the duration to reduce interference to the second device served by the second communications controller (step 710), wherein the precoding constraint blanks out a portion of a transmission coverage area of the first communication controller occupied by the second device and serves for adjusting a precoder; • transmitting, by the first communications controller, coordinated transmission information about the time-frequency resource, the duration, and the precoding constraint, to the second communication controller (step 720); and • transmitting, by the first communications controller, to the first device in accordance with the precoding constraint, the time-frequency resource, and the duration (step 725). • receiving, by the first communications controller, channel information for a communications channel between the first communication controller and a second device served by a second communications controller, wherein the channel information comprises a channel covariance matrix providing directional information of the second communication controller and the second device (step 705); • deriving, by the first communications controller, a time-frequency resource, a duration, and a precoding constraint in accordance with the received channel information, the precoding constraint being derived using said channel covariance matrix, and the precoding constraint being for use with a transmission of the first communications controller occurring within the time-frequency resource for the duration to reduce interference to the second device served by the second communications controller (step 710), wherein the precoding constraint blanks out a portion of a transmission coverage area of the first communication controller occupied by the second device and serves for adjusting a precoder; • transmitting, by the first communications controller, coordinated transmission information about the time-frequency resource, the duration, and the precoding constraint, to the second communication controller (step 720); and • transmitting, by the first communications controller, to the first device in accordance with the precoding constraint, the time-frequency resource, and the duration (step 725).
A therapeutically effective amount of an IR700-molecule conjugate for use in treatment regimen for removing a target from a subject comprising: i) administering to a subject a therapeutically effective amount of an IR700-molecule conjugate, wherein the molecule of the IR700-molecule conjugate comprises the target or wherein the molecule comprises a specific binding agent that specifically binds to the target; ii) forming a hydrophobic IR700-molecule conjugate after irradiating the subject under irradiation conditions at a wavelength of 660 nm to 710 nm and at a dose of at least 4 J cm -2 and allowing the hydrophobic IR700-molecule conjugate to aggregate; and iii) detecting a decrease in the amount of the target molecule in the subject or detecting an increase in the amount of the target molecule removed from the subject.. i) administering to a subject a therapeutically effective amount of an IR700-molecule conjugate, wherein the molecule of the IR700-molecule conjugate comprises the target or wherein the molecule comprises a specific binding agent that specifically binds to the target; ii) forming a hydrophobic IR700-molecule conjugate after irradiating the subject under irradiation conditions at a wavelength of 660 nm to 710 nm and at a dose of at least 4 J cm -2 and allowing the hydrophobic IR700-molecule conjugate to aggregate; and iii) detecting a decrease in the amount of the target molecule in the subject or detecting an increase in the amount of the target molecule removed from the subject..
A composition comprising an isocyanate compound comprising an isocyanate group in a molecule, in which the isocyanate group is not directly bonded to an aromatic ring, a compound comprising an active hydrogen-containing group, and a reaction accelerator, which is a compound comprising a halogenated carbamoyl group and a (meth)acryloyl group, wherein the amount of the reaction accelerator is in a range of 3000 ppm by mass to 20000 ppm by mass with respect to an amount (100% by mass) of the isocyanate compound.
A method of manufacturing a porous separator using cellulose nanofibrils, comprising: manufacturing a sheet using a solution including cellulose nanofibrils and a pore-forming resin; and removing the pore-forming resin to form micropores in the sheet, wherein the cellulose nanofibrils are at least one selected from the group consisting of cellulose nanofibrils separated from a woody material, algae cellulose nanofibrils, and bacterial cellulose nanofibrils obtained by incubating a strain, wherein the pore-forming resin is at least one selected from the group consisting of polyethylene glycol, polypropylene alcohol, and polyvinyl propylene, wherein manufacturing the sheet is performed by passing a solution including the cellulose nanofibrils and the pore-forming resin through a high-pressure homogenizer to make a cellulose nanofibrils suspension and decompressing the suspension to make the sheet, wherein removing the pore-forming resin is performed by immersing the sheet in a solvent, wherein the solvent dissolves the pore-forming resin and does not dissolve the cellulose nanofibrils, wherein a mixing ratio of the cellulose nanofibrils and the pore-forming resin is 8:2 to 5:5 (w/w). manufacturing a sheet using a solution including cellulose nanofibrils and a pore-forming resin; and removing the pore-forming resin to form micropores in the sheet, wherein the cellulose nanofibrils are at least one selected from the group consisting of cellulose nanofibrils separated from a woody material, algae cellulose nanofibrils, and bacterial cellulose nanofibrils obtained by incubating a strain, wherein the pore-forming resin is at least one selected from the group consisting of polyethylene glycol, polypropylene alcohol, and polyvinyl propylene, wherein manufacturing the sheet is performed by passing a solution including the cellulose nanofibrils and the pore-forming resin through a high-pressure homogenizer to make a cellulose nanofibrils suspension and decompressing the suspension to make the sheet, wherein removing the pore-forming resin is performed by immersing the sheet in a solvent, wherein the solvent dissolves the pore-forming resin and does not dissolve the cellulose nanofibrils, wherein a mixing ratio of the cellulose nanofibrils and the pore-forming resin is 8:2 to 5:5 (w/w).
Charging station for a consumer with a charging interface with electrodes (6a, b) for the contacting coupling of the consumer, wherein the consumer has a mating interface, a charging facility and an energy storage device, wherein the mating interface is interconnected with the energy storage device via the charging facility, so that the energy storage device can be charged via the mating interface, with a supply facility for supplying the charging interface, wherein the supply facility can be set into a charging state and a non-charging state, with a detection facility for detecting the coupling of the consumer to the charging interface, wherein the detection facility is embodied, when the supply facility is in a non-charging state, to acquire an electrical variable based on the energy storage voltage of the energy storage device as detection variable for detecting the coupling of the consumer to the charging interface, and wherein the charging facility has a blocking diode, characterised in that the detection variable is embodied as a reverse current through the blocking diode, and a load resistance is provided between the electrodes (6a, b) of the charging interface, wherein less than 95% of the voltage present at the electrodes (6a, b) of the charging interface drops at the load resistance, and the charging station contains a control facility, wherein the control facility is embodied to switch the supply facility between the charging state and the non-charging state on the basis of the detection variable. with a charging interface with electrodes (6a, b) for the contacting coupling of the consumer, wherein the consumer has a mating interface, a charging facility and an energy storage device, wherein the mating interface is interconnected with the energy storage device via the charging facility, so that the energy storage device can be charged via the mating interface, with a supply facility for supplying the charging interface, wherein the supply facility can be set into a charging state and a non-charging state, with a detection facility for detecting the coupling of the consumer to the charging interface, wherein the detection facility is embodied, when the supply facility is in a non-charging state, to acquire an electrical variable based on the energy storage voltage of the energy storage device as detection variable for detecting the coupling of the consumer to the charging interface, and wherein the charging facility has a blocking diode, characterised in that the detection variable is embodied as a reverse current through the blocking diode, and a load resistance is provided between the electrodes (6a, b) of the charging interface, wherein less than 95% of the voltage present at the electrodes (6a, b) of the charging interface drops at the load resistance, and the charging station contains a control facility, wherein the control facility is embodied to switch the supply facility between the charging state and the non-charging state on the basis of the detection variable.
Drive arrangement in a vehicle having front and rear ground engaging means and steering means comprising a planetary final drive on each side of the vehicle and a motor acting onto one member of the planetary final drives depending on the steering angle and in inverse direction, characterized in that the drive arrangement for the front and/or rear ground engaging means further comprises a differential transmission with a differential lock.
An actuator, comprising: a plate; an actuating member, movably mounted to the plate and operable to be moved between a first position and a second position; a selectively-contractible wire formed from a shape memory alloy connected to the actuating member and operable to move the actuating member to one of the first and second positions from the other of the first and second positions to activate the actuator; characterized in that at least one portion of the selectively-contractible wire is annealed to reduce its ability to selectively contract, whereby a transitional region of the wire situated proximate to the annealed portion of the wire is partially annealed to provide strain relief. a plate; an actuating member, movably mounted to the plate and operable to be moved between a first position and a second position; a selectively-contractible wire formed from a shape memory alloy connected to the actuating member and operable to move the actuating member to one of the first and second positions from the other of the first and second positions to activate the actuator; characterized in that at least one portion of the selectively-contractible wire is annealed to reduce its ability to selectively contract, whereby a transitional region of the wire situated proximate to the annealed portion of the wire is partially annealed to provide strain relief.
A method of collecting cord blood stem cells, comprising: providing a partially exsanguinated mammalian placenta that has been isolated comprising cord blood comprising cord blood stem cells; performing pulsatile machine perfusion of the isolated partially exsanguinated mammalian placenta with a pressure mediated pulsatile flow of a perfusion solution to produce a perfusate comprising cord blood comprising cord blood stem cells; collecting the perfusate; and isolating the cord blood stem cells from the perfusate to produce isolated cord blood stem cells; wherein the placenta is not administered or injected with an anticoagulant prior to perfusing. providing a partially exsanguinated mammalian placenta that has been isolated comprising cord blood comprising cord blood stem cells; performing pulsatile machine perfusion of the isolated partially exsanguinated mammalian placenta with a pressure mediated pulsatile flow of a perfusion solution to produce a perfusate comprising cord blood comprising cord blood stem cells; collecting the perfusate; and isolating the cord blood stem cells from the perfusate to produce isolated cord blood stem cells; wherein the placenta is not administered or injected with an anticoagulant prior to perfusing.